If you want a comfortable retirement, annuitize a portion of your retirement savings and don't take Social Security benefits early. Read More
Jim Fink is chief investment strategist for Options for Income, Velocity Trader, and Jim Fink's Inner Circle. He has traded options for more than 30 years and generated personal profits of more than $5 million. Jim also serves as an investment analyst at Investing Daily’s flagship investing publication, Personal Finance.
Hopelessly overeducated, Jim holds a bachelor's degree from Yale University, a master's degree from Harvard's Kennedy School of Government, a law degree from Columbia University, and an MBA from the University of Virginia's Darden School of Business. For good measure, he has been a member of the Illinois and D.C. bars.
Prior to joining Investing Daily, and when not incurring student loans hiding out in academe, Jim practiced telecommunications regulatory law for nine years until he realized that he made more money trading stock options than writing briefs. After attending business school, Jim switched gears to the investment realm full-time, working for a university endowment, a private wealth management firm, an insurance and financial planning company, and as a Senior Analyst for an online investment newsletter service that encourages the wearing of funny hats.
A possible but unlikely descendant of legendary brawler and boatman Mike Fink, Jim defies his heritage, believing that investing success requires patience and analysis, not swashbuckling bravado. Besides his passion for analyzing and writing about stocks, Jim likes to hike in the desert Southwest, vacation in Las Vegas, play tennis, and feed his toddler son Cheerios.
Analyst Articles
We're rolling three covered calls with January expirations to later expiration months. Two more will be assigned, and one portfolio stock gets reintroduced to a covered call. Read More
Bill Ackman is getting squeezed on his Herbalife short by hedge fund managers who don't like him much. Never disclose your shorts. Read More
Jim re-evaluates the cash flow vs. earnings debate and concludes that both are important for stock picking but for different reasons. And don't forget sales! Read More
Herbalife is either in big regulatory trouble or one of the best investment opportunities of the coming years. Can Bill Ackman convince the Federal Trade Commission to take action? Read More
We're rolling three covered calls from December expirations to March expirations. Read More
Is the Federal Reserve's latest money-printing scheme an effort to stoke inflation and monetize the national debt? Bad news for bonds. Read More
China's economy may finally be rebounding, but U.S. investors in Chinese ADRs may find it difficult to benefit. Read More
New research concludes that investors can benefit from the January Effect without dumpster diving in microcaps or companies with scary price declines. Jim offers some ideas. Read More
November means 13F filing season, which allows us to peek into the minds of the world's greatest investors. Internet and specialty financials are in while PC-related technology is out. Read More